|
U s Neurosurgical Holdings Inc (USNU) |
|
U s Neurosurgical Holdings Inc
USNU's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
U S Neurosurgical Holdings Inc 's sales fell
in II. Quarter 2024 from the same quarter a year ago.
Healthcare Facilities industry recorded
growth of revenues by 7.26 %
U S Neurosurgical Holdings Inc net loss decreased from $-1 millions, to $0 millions in II. Quarter 2024,
• More on USNU's Growth
|
|
U S Neurosurgical Holdings Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 5.92 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
17.28 |
PE TTM
|
|
Healthcare Facilities industry's Price to Sales ratio is at 1.27.
• More on USNU's Valuation
|
|
|
|
|
U S Neurosurgical Holdings Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 5.92 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
17.28 |
PE TTM
|
|
Healthcare Facilities industry's Price to Sales ratio is at 1.27.
U S Neurosurgical Holdings Inc Price to Book Ratio is at 4.2 lower than Industry Avg. of 606.71. and higher than S&P 500 Avg. of 0
• More on USNU's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com